IMPROVEMENTS OVER TIME WITH LONG-TERM VALBENAZINE IN OLDER AND ELDERLY PATIENTS WITH TARDIVE DYSKINESIA

被引：0
|
作者：
Sajatovic, Martha [2 ,3 ]
Alexopoulos, George [1 ]
Roque, Autumn [4 ]
Jen, Eric [4 ]
Lundt, Leslie [4 ]
机构：
[1] Weill Cornell Med Coll, New York, NY USA
[2] Case Western Reserve Univ, Sch Med, Cleveland, OH USA
[3] Univ Hosp Clev, Cleveland, OH USA
[4] Neurocrine Biosci Inc, San Diego, CA USA
来源：
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY | 2023年 / 31卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
NR-36
引用
收藏
页码：S126 / S127
页数：2
相关论文
共 50 条
  • [31] Patterns of Improvement in Tardive Dyskinesia: Post-Hoc Analysis of a Long-Term Study with Valbenazine (KINECT 4)
    Correll, Christoph U.
    Carmack, Tara
    Shah, Chirag
    Lundt, Leslie
    ANNALS OF NEUROLOGY, 2021, 90 : S148 - S149
  • [32] TARDIVE-DYSKINESIA AND THE LONG-TERM PATIENT
    SCHWARTZ, HJ
    HOSPITAL AND COMMUNITY PSYCHIATRY, 1979, 30 (07): : 465 - 467
  • [33] LONG-TERM TREATMENT OF TARDIVE-DYSKINESIA
    JUS, A
    JUS, K
    FONTAINE, P
    JOURNAL OF CLINICAL PSYCHIATRY, 1979, 40 (02) : 72 - 77
  • [34] Effects of long-term valbenazine in patients with tardive dyskinesia and a primary mood disorder: Results from an open-label, rollover study
    McIntyre, Roger
    Marder, Stephen
    Verghese, Cherian
    Shah, Chirag
    Farahmand, Khodayar
    BIPOLAR DISORDERS, 2020, 22 : 109 - 109
  • [35] Characteristics of Patients With Tardive Dyskinesia Who Maintain Treatment Response After Discontinuing Long-Term Valbenazine: Pooled Analysis of Two Trials
    Caroff, Stanley
    Lindenmayer, Jean-Pierre
    Farahmand, Khodayar
    Burke, Joshua
    Siegert, Scott
    NEUROPSYCHOPHARMACOLOGY, 2018, 43 : S321 - S321
  • [36] Effects of Long-Term Valbenazine on Tardive Dyskinesia and Patient-Reported Outcomes: Results from the KINECT 4 Study
    Factor, Stewart
    Kane, John
    Marder, Stephen
    Hauser, Robert
    Farahmand, Khodayar
    Jimenez, Roland
    Burke, Joshua
    Siegert, Scott
    Liang, Grace
    NEUROLOGY, 2018, 90
  • [37] LONG-TERM EFFECTS OF VALBENAZINE ON TARDIVE DYSKINESIA IN PATIENTS WITH SCHIZOPHRENIA/SCHIZOAFFECTIVE DISORDER: RESULTS FROM AN OPEN-LABEL, ROLLOVER STUDY
    Kane, John
    Marder, Stephen
    Lindenmayer, Jean-Pierre
    Jimenez, Roland
    Farahmand, Khodayar
    Siegert, Scott
    SCHIZOPHRENIA BULLETIN, 2019, 45 : S199 - S200
  • [38] GLOBAL IMPROVEMENTS IN TARDIVE DYSKINESIA AND PATIENT SATISFACTION WITH VALBENAZINE IN OLDER AND YOUNGER PATIENTS: RESULTS FROM AN OPEN-LABEL, ROLLOVER STUDY
    Sajatovic, Martha
    Lindenmayer, Jean-Pierre
    Burke, Joshua
    Jimenez, Roland
    Farahmand, Khodayar
    Siegert, Scott
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2019, 27 (03): : S175 - S175
  • [39] ONCE-DAILY VALBENAZINE IS EFFECTIVE FOR TARDIVE DYSKINESIA IN ELDERLY PATIENTS (>=65 YEARS)
    Sajatovic, Martha
    Farahmand, Khody
    Shah, Chirag
    Lundt, Leslie
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2022, 30 (04): : S67 - S68
  • [40] Treatment Success and Psychiatric Stability in Adults With Tardive Dyskinesia: Post Hoc Analyses of Two Long-Term Valbenazine Studies
    Cutler, Andrew J.
    Jain, Rakesh
    Bloom, Alon
    Siegert, Scott
    Lundt, Leslie
    CNS SPECTRUMS, 2023, 28 (02) : 216 - 217
12345